KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Receivables - Net: 2009-2024

Historic Receivables - Net for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $1.3 billion.

  • Quest Diagnostics' Receivables - Net rose 5.81% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 5.81%. This contributed to the annual value of $1.3 billion for FY2024, which is 7.77% up from last year.
  • According to the latest figures from FY2024, Quest Diagnostics' Receivables - Net is $1.3 billion, which was up 7.77% from $1.2 billion recorded in FY2023.
  • Quest Diagnostics' 5-year Receivables - Net high stood at $1.5 billion for FY2020, and its period low was $1.2 billion during FY2022.
  • Over the past 3 years, Quest Diagnostics' median Receivables - Net value was $1.2 billion (recorded in 2023), while the average stood at $1.2 billion.
  • Its Receivables - Net has fluctuated over the past 5 years, first soared by 42.99% in 2020, then declined by 16.90% in 2022.
  • Quest Diagnostics' Receivables - Net (Yearly) stood at $1.5 billion in 2020, then dropped by 5.39% to $1.4 billion in 2021, then dropped by 16.90% to $1.2 billion in 2022, then rose by 1.26% to $1.2 billion in 2023, then climbed by 7.77% to $1.3 billion in 2024.